Request Demo
Last update 08 May 2025
TQD-3606
Last update 08 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism β-lactamase inhibitors(Beta Lactamase inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
5
Clinical Trials associated with TQD-3606CTR20234042
评价注射用TQD3606在肾功能不全受试者中的药代动力学和安全性的开放、平行、单次给药的I期临床研究
[Translation] An open-label, parallel, single-dose phase I clinical study to evaluate the pharmacokinetics and safety of TQD3606 for injection in subjects with renal insufficiency
NCT06672276
An Open, Parallel, Single-dose Phase I Clinical Study to Evaluate the Pharmacokinetics and Safety of TQD3606 for Injection in Subjects With Renal Insufficiency
CTR20232855
评价注射用TQD3606在健康受试者中单中心、不同给药时长、不同给药间隔的药代动力学特征及安全性、耐受性的I期临床研究。
[Translation] A phase I clinical study to evaluate the pharmacokinetic characteristics, safety and tolerability of TQD3606 for injection in healthy subjects at a single center with different dosing durations and dosing intervals.
100 Clinical Results associated with TQD-3606
Login to view more data
100 Translational Medicine associated with TQD-3606
Login to view more data
100 Patents (Medical) associated with TQD-3606
Login to view more data
100 Deals associated with TQD-3606
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anaerobic bacterial infection | Phase 1 | China | 18 Nov 2024 | |
| Gram-Negative Bacterial Infections | Phase 1 | China | 18 Nov 2024 | |
| Gram-Positive Bacterial Infections | Phase 1 | China | 18 Nov 2024 | |
| Carbapenem Resistant Bacterial Infection | Phase 1 | China | 04 Nov 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free